Antibody Therapeutics for Life
Press Release
| PharmAbcine to present the final data of Phase IIa rGBM trial at SNO 2020 | ||||||
|
||||||
|
||||||
|
List
|
||||||
| Prev | PharmAbcine to participate at BIO-Europe 2020 |
| Next | No next post. |
- 2F, Research Building 2, 70, Yuseong-daero 1689 beon-gil,
Yuseong-gu, Daejeon, 34047, Republic of Korea - HQ +82-42-863-2017
- R&D Center +82-42-861-2017
- FAX +82-42-863-2080
COPYRIGHT BY PharmAbcine Inc. ALL RIGHTS RESERVED.